Syneron Medical (NASDAQ:ELOS) will report earnings before markets open on Wednesday, August 14th. Syneron Medical Ltd. designs, develops, and markets aesthetic medical products based on proprietary Electro-Optical Synergy, or ELOS technologies. The Company’s products include Aurora – Hair Removal, Skin Treatment and Acne treatment systems.
Here is your Cheat Sheet to Syneron Medical Earnings:
Earnings Expectations: Analysts expect earnings of $0.09 per share on revenues of $70.93 million.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.11 to a profit $0.1. For the current year, the average estimate is a profit of $0.42, which is worse than the estimate ninety days ago.
Here’s how Syneron Medical has been performing on an annual basis:
|Revenue ($) in millions||115||55||190||228||264|
|Diluted EPS ($)||0.20||-0.86||-0.74||-1.35||-0.04|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||68.07||60.13||72.76||61.20|
|Diluted EPS ($)||-0.05||-0.06||0.14||-0.07|
Syneron Medical has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)